Form D · Venture Capital Fund
Healthcare Innovation Fund, L.P.
Saint Louis, MO · CIK 0001838271
Offering snapshot reported Oct 31, 2022 · SEC filing
- Reported sold
- $10.4M Offering amount: $25M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Dec 23, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$6,060,000 → $10,385,000
- Reported investors13 → 26
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2022 | Amendment | $10,385,000 | $4,325,000vs Jan 6, 2021 | 26 | SEC filing |
| Jan 6, 2021 | Initial | $6,060,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-385431
The Issuer is offering $25 million but has reserved the right to offer up to $50 million.
Source: Form D, filed Oct 31, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
HEALTHCARE INNOVATION FUND, LP
Investment adviser: CULTIVATION CAPITAL, LLC
- Gross asset value
- $9.6M
- Beneficial owners
- 19
- ADV minimum commitment
- $500K
Reported in Form ADV on Jun 9, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
No provider names available in this fund's imported disclosure.
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
Filing source
Form ADV 2112182 · Jun 9, 2026 · Schedule D 7.B.(1), fund 805-6241816815
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Edmond Bakken | Director, Promoter |
| Cultivation Capital, Llc | Promoter |
| Healthcare Innovation Gp, Llc | Director, Promoter |
| Health X Management, Llc | Promoter |
| Elise Miller Hoffman | Director, Promoter |
| Taha Yasin Jangda | Director, Promoter |
| Pandemic Innovation Gp, Llc | Director, Promoter |
| William Raymond Schmidt | Director, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Saint Louis, MO, 63132